TIANAN MEDICARE (00383) announces annual performance results, with a net loss attributable to shareholders of 26.816 million Hong Kong dollars, a year-on-year profit to loss conversion.

TIANAN MEDICARE (00383) released its annual performance as of December 31, 2025. The group achieved a revenue of HK$1.638 billion, an increase of 0.67% compared to the previous year. The company's attributable loss was HK$268.16 million, compared to a profit of HK$287.73 million in the same period last year. The basic loss per share was 2.48 Hong Kong cents. The announcement stated that the company's attributable loss was mainly due to a fair value loss of HK$74.07 million on investment properties (HK$16.921 million in 2024); provisions for development properties available for sale of HK$23.86 million (HK$10.957 million in 2024); provisions for properties held for sale of HK$10.322 million (HK$1.664 million in 2024); offset by a net exchange gain of HK$8.126 million (a loss of HK$15.244 million in 2024); and no offsetting of the loss from closing comprehensive outpatient services in 2024.